CLINICAL TRIALS PROFILE FOR DERMATOP

All Clinical Trials for DERMATOP

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00148746 ↗	Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis	Completed	Technische Universität Dresden	N/A	2004-05-01	The study was designed to test the hypothesis whether a standardized, time-and score-oriented treatment following a strict evidence based algorithm is equally effective to a standard treatment regimen for moderate to severe atopic dermatitis. Study Type: Mono-centre study, patients are blinded, physicians are randomized to either treat study- or controll group Eligible are patients age 2 years or older with SCORAD >= 20 Duration: 12 Months, study visits every 4 weeks. Primary endpoint is Difference between Baseline SCORAD and mean SCORAD under treatment. Secundary endpoints are quality of life, safety and economic burden in both treatment groups.

Clinical Trial Conditions for DERMATOP

Condition Name

Condition Name for DERMATOP
Intervention	Trials
Moderate to Severe Atopic Dermatitis	1

Condition MeSH

Condition MeSH for DERMATOP
Intervention	Trials
Dermatitis, Atopic	1
Dermatitis	1
Eczema	1

Clinical Trial Locations for DERMATOP

Trials by Country

Trials by Country for DERMATOP
Location	Trials
Germany	1

Clinical Trial Progress for DERMATOP

Clinical Trial Phase

Clinical Trial Phase for DERMATOP
Clinical Trial Phase	Trials
N/A	1

Clinical Trial Status

Clinical Trial Status for DERMATOP
Clinical Trial Phase	Trials
Completed	1

Clinical Trial Sponsors for DERMATOP

Sponsor Name

Sponsor Name for DERMATOP
Sponsor	Trials
Technische Universität Dresden	1

Sponsor Type

Sponsor Type for DERMATOP
Sponsor	Trials
Other	1